We generated a rnhA recG proB::rnhA + strain in which the recG deletion was covered by pJJ100 (pRC7 recG + ). As shown in Figure 3A, only very small

white colonies were observed after incubation for 48 h on LB agar without arabinose. These white colonies are formed due to the leakiness of the araBAD promoter. In contrast, on LB agar with moderate arabinose concentrations robust segregation of blue and white colonies was observed, with the white colonies being as healthy as the blue. Thus, expression of the integrated rnhA construct can be regulated by the presence or absence of arabinose. Figure 3 The lethality of ΔtopA cells is not suppressed by increased levels of RNase HI. (A) Expression GDC-0973 cost of a P araBAD rnhA construct integrated into the chromosome can be regulated by different arabinose concentrations. The expression level is high enough to suppress the synthetic lethality of rnhA recG cells. (B) Expression from the integrated P araBAD rnhA construct does not suppress the lethality of ΔtopA cells. The P araBAD rnhA construct has been integrated into a rnhA + background. Thus, expression of the construct will produce RNase HI in addition to the regular rnhA locus. (C) Expression from the integrated P araBAD rnhA construct does not improve growth of cells in which the ΔtopA

defect is partially suppressed by overexpression of DNA topoisomerase III. The image for AS1066 was reproduced from Figure 2 for comparison. Please note that incubation and image capturing procedures are standardised to allow comparison of colony find more sizes To test whether increased MG-132 price levels of RNase HI can suppress the lethality of topA strains

we integrated our proB::rnhA + expression construct into an rnhA + background. Thus, any expression from our integration construct will be in addition to the expression from the native rnhA gene. We then introduced our topA::apra allele, covering the deletion with the pRC7 topA plasmid. However, growth of this strain in medium with moderate (data not shown) or high arabinose concentrations did not lead to formation of white colonies (Figure 3B). Since we did not directly measure the concentration of RNase HI in cells we cannot exclude the possibility that the levels in our expression constructs are not high enough for suppression of the ΔtopA phenotype. We therefore wanted to test the expression of rnhA in a system that might be more sensitive for low expression levels. It was observed before that the co-expression of both rnhA and topB resulted in a synergistic suppression of the topA phenotype [14]. We therefore wanted to know whether the expression of rnhA from our integration construct would increase the suppression of the observed topB overexpression. To test this we transformed our ptopA/ΔtopA ΔproB::rnhA + background with the topB expression plasmid. However, co-expression did not lead to an increase in the size of the white colonies. If anything a mild reduction of viability is observed (Figure 3C).

Tabak LA: GSK126 The role of mucin-type O -glycans in eukaryotic development. Semin Cell Dev Biol 2010, 21:616–621.PubMedCrossRef 9. Lang T, Hansson GC, Samuelsson T: Gel-forming mucins appeared early in metazoan evolution. Proc Natl Acad Sci U S A 2007, 104:16209–16214.PubMedCrossRef 10. Lang T, Alexandersson M, Hansson GC, Samuelsson T: Bioinformatic identification of polymerizing and transmembrane mucins in the puffer fish Fugu rubripes . Glycobiology 2004, 14:521–527.PubMedCrossRef 11. Espino JJ, Brito N, Noda J, González C: Botrytis cinerea endo-ß-1,4-glucanase Cel5A

is expressed during infection but is not required for pathogenesis. Physiol Mol Plant Pathol 2005, 66:213–221.CrossRef 12. Julenius K, Molgaard A, Gupta R, Brunak S: Prediction,

conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites. Glycobiology 2005, 15:153–164.PubMedCrossRef 13. NetOGlyc 3.1 Server. http://​www.​cbs.​dtu.​dk/​services/​NetOGlyc 14. Jensen PH, Kolarich D, Packer NH: Mucin-type O -glycosylation–putting the pieces together. FEBS J 2010, Seliciclib mw 277:81–94.PubMedCrossRef 15. Lambrechts MG, Bauer FF, Marmur J, Pretorius IS: Muc1, a mucin-like protein that is regulated by Mss10, is critical for pseudohyphal differentiation in yeast. Proc Natl Acad Sci U S A 1996, 93:8419–8424.PubMedCrossRef 16. The Carbohydrate-Active enZYmes (CAZy) database. http://​www.​cazy.​org 17. Cantarel BL, Coutinho PM, Rancurel C, Bernard T, Lombard V, Henrissat B: The Carbohydrate-Active EnZymes database (CAZy): an expert resource for Glycogenomics. Nucl Acids Res 2009, 37:D233-D238.PubMedCrossRef 18. Fankhauser N, Maser P: Identification of GPI anchor attachment signals by a Kohonen self-organizing map. Bioinformatics Fluorometholone Acetate 2005, 21:1846–1852.PubMedCrossRef 19. Eisenhaber B, Schneider G, Wildpaner M, Eisenhaber F: A Sensitive Predictor for Potential GPI Lipid Modification Sites in Fungal Protein

Sequences and its Application to Genome-wide Studies for Aspergillus nidulans, Candida albicans Neurospora crassa, Saccharomyces cerevisiae and Schizosaccharomyces pombe . J Mol Biol 2004, 337:243–253.PubMedCrossRef 20. Shimoi H, Kitagaki H, Ohmori H, Iimura Y, Ito K: Sed1p is a major cell wall protein of Saccharomyces cerevisiae in the stationary phase and is involved in lytic enzyme resistance. J Bacteriol 1998, 180:3381–3387.PubMed 21. Kulkarni RD, Kelkar HS, Dean RA: An eight-cysteine-containing CFEM domain unique to a group of fungal membrane proteins. Trends Biochem Sci 2003, 28:118–121.PubMedCrossRef 22. Timpel C, Zink S, Strahl-Bolsinger S, Schroppel K, Ernst J: Morphogenesis, adhesive properties, and antifungal resistance depend on the Pmt6 protein mannosyltransferase in the fungal pathogen candida albicans. J Bacteriol 2000, 182:3063–3071.PubMedCrossRef 23. Espino JJ, Gutiérrez-Sánchez G, Brito N, Shah P, Orlando R, González C: The Botrytis cinerea early secretome. Proteomics 2010, 10:3020–3034.PubMedCrossRef 24.

Z Elektrochem 64:187–203 Brody S (1970) The effects of linolenic acid and extracts of Ricinus

leaf on system I and system II. Z Naturforschung 25:855–859 Brody SS (1995) We remember Eugene (Rabinowitch and his laboratory during the fiflies). Photosynth Res 43:67–74CrossRef Brody SS (2002) Fluorescence lifetime, yield, energy transfer and spectrum in photosynthesis, 1950–1960. Photosynth Res 73:127–132CrossRefPubMed Brody SS, Brody M (1959) Induced changes in the efficiency of energy transfer in Porphyridium cruentum I. Arch Biochem Biophys 82:161–178CrossRefPubMed Brody SS, Brody M (1961) Spectral characteristics of aggregated chlorophyll and its possible role in photosynthesis. Nature (London) 189:547–549CrossRef Brody SS, Brody M (1965) An experiment showing that P700 can be an aggregated form of chlorophyll a. Arch Biochem Biophys 110:583–585CrossRefPubMed

Brody SS, Rabinowitch E (1957) Excitation lifetimes EPZ015666 cost of photosynthetic pigments in vivo and in vitro. Science 125:555–557CrossRefPubMed Brody SS, Rabinowitch E (1959) Energy transfer and photosynthesis. First National Biophysics Conference, Yale University Press, pp 110–121 Brody SS, Stelzig L (1983) Effect of pressure on the absorption spectra of phycobiliprotein and Porphyridium cruentum. Z Naturforsch 38c:458–460 Brody SS, Brody M, Levine SB525334 J (1965) Fluorescence changes during chlorophyll formation in Euglena gracilis (and other organisms) and an estimate of lamellar area as a function of age. J Protozool 12:465–476PubMed Brody SS, Brody M, Döring G (1970) Effects

of linolenic acid on system II and system I—associated light induced changes in absorption of chloroplasts. Zeit f Naturforschgung 25b:367–372 Brody SS, Stelzig L, Ferraro G, Rich M (1987) Use of elevated pressure to promote the Vildagliptin difference in permeability of adriamycin (C) and hematoporphyrin between neoplastic and normal lung cells. Cancer Biochem Biophys 9:l33–l38 Brody SS, Papageorgiou G, Alygizaki-Zorba A (1997) Photodynamic action of hypericin on cyanobacteria Synechocystis and Synechococcus (Anacystis nidulans). Z Naturforsch 52c:165–168 Brody SS, Gough SP, Kannangara CG (1999) Predicted structure and fold recognition for the glutamyl tRNA reductase family of proteins. Proteins 37:485–493CrossRefPubMed Clegg RM, Sener M, Govindjee (2010) From Förster Resonance Energy Transfer (FRET) to Coherent Resonance Energy Transfer (CRET) and Back—Awheen o’ mickles mak’s a muckle. In: Alfano RR (ed) Optical biopsy VII, Proceedings of SPIE, Vol. 7561 (SPIE, Bellingham, WA, 2010), paper number: 7561-12; article CID number: 75610C, 21 pp Dmitrievsky OD, Ermolaev VL, Terenin AN (1957) The fluorescence lifetime of chlorophyll a in Chlorella cells. Proc USSR Acad Sci 114:75–78 Dutton H (1997) Carotenoid-sensitized photosynthesis: quantum efficiency, fluorescence and energy transfer.

Gene transfer between phylogenetically remote bacteria would be favored by colonization of the same environmental niche [63]. In nature, Rhizobium is normally viewed as a microbe that survives saprophytically in soil, in nitrogen fixing nodules of legumes or as endophytes in gramineous plants, for example field grown [64] and wild rice

[65]. P. syringae pv phaseolicola 1448A and P. syringae pv oryzae str.1_6 are pathogens of the common bean and rice, respectively, while Rhizobium Selleckchem S3I-201 sp. NGR234 forms nitrogen fixing nodules with more legumes than any other microsymbiont [38]. Thus, there is ample opportunity for niche overlap between at least one of the P. syringae pathovars possessing T3SS-2 and Rhizobium sp. NGR234. At this point, a role for T3SS-2 in host-bacterium interactions for the rhizobia or the P. syringae strains possessing the system remains to be established and it buy SIS3 is not obvious why these bacteria maintain a second T3SS gene cluster in their genome. Functional analysis and genome sequencing of more rhizobia that share common niches with P. syringae as well as the sequencing of more P. syringae pathovar genomes may shed light into

these questions. Acknowledgements We thank Ioanna Eleftheriadou for assistance in the initial search for T3SS related ORFs in the P. syringae pv phaseolicola 1448a genome. This work was supported by PENED, PYTHAGORAS and PEP (KP-15) grants from the Greek Ministry of Education, GSRT and the EPEAEK-Plant Molecular Biology and Biotechnology and the Protein Biotechnology graduate programs. S.N.C. was recipient of an Onassis Foundation fellowship

and a GSRT post-doctoral grant. V.E.F is supported by a Marie Curie Reintegration Grant. Electronic supplementary material Additional file 1: Figure S1: Unrooted neighbor-joining phylogenetic tree of SctQ proteins of flagellar and non-flagellar T3S proteins. The tree was DAPT mouse calculated by CLUSTALW (1.82) using bootstrapping (500 replicates) as a method for deriving confidence values for the groupings and was drawn by MEGA 4.0. Bootstrap values are indicated in each branching point. Scale bar represents numbers of substitution per site. The arrow indicates a possible position of root so that the tree will be compatible with the monophyly of the flagellar T3SS. Consistently with phylograms based on other conserved proteins of the Pph T3SS-2, the Hrc II Q polypeptide does not fall into any of the two Hrc1/Hrc2 T3SS families but it is grouped with the Rhc family. (PDF 388 KB) Additional file 2: Figure S2.: Unrooted neighboring joining tree including all known SctV T3SS families and the flagelar proteins. Bootstrap values are percentages of 500 repetitions taking place. Multiple alignment performed with ClustalW. (PDF 163 KB) Additional file 3: Figure S3: Evolutionary relationships of 250 HrcN/YscN/FliI proteins. A.

Accordingly, a major experimental task now is to detect such small replicators, and study possible ribonucleotide OICR-9429 research buy origins by examining their properties (Yarus 2012). In this work, new properties for the earliest selectable replicating system (the IDA)

appear, implicit in the apparently simple chemistry of the sporadically fed pool. Crucial Templating Events In A Sporadically Fed Pool A standard sporadically fed pool is poised just above the ‘Darwinian boundary’ (Yarus 2012) at which net templated replication begins. Thus the properties of the standard pool should account for this beginning. Net replication (Fig. 1) is specifically associated with a class of efficient templated AB synthesis events (Fig. 2). Such association of template and product is a quality expected of replication, but not of direct chemical AB synthesis. Considering measurements on 250 individual synthetic episodes, elevated production of AB can be traced to a specific subset of synthetic episodes in which multiple A and B spikes-at-random intersect a single surviving population of AB templates (Fig. 3). These productive syntheses are a substantial minority of all synthetic episodes Target Selective Inhibitor Library (Fig. 4). With one spike of A or B every 10 A or B lifetimes,

most total AB synthesis occurs in events involving 4, 5 or 6 spikes of substrate, thereby constituting a near-ideal reactor Fossariinae for replication (Fig. 5). Such

sporadic trains of substrate spikes are near-ideal because they both increase available nucleotide concentrations, and also ensure that A and B are available while template AB exists (Fig. 6), thereby generating net replication. A More Precise Description Of The Darwinian Transition Previous discussion of the sporadically fed pool was conducted in terms of the requirements for net replication over time (Yarus 2012); that is, for transfer of information to descendant AB molecules during pool lifetimes, thereby permitting Darwinian evolution. Because we now know that replication near the Darwinian boundary occurs during particular substrate spike trains, prior conclusions can be restated in more explicit molecular terms. For example, there is very strong internal selection for molecular stability in the sporadically fed pool, which, given variance in stability, will drive the pool toward replication and Darwinism (Yarus 2012). This inevitable stability selection can now be recognized as the effect of longer-surviving reactants on the assembly of effective episodes of synthesis, which necessarily require the co-survival of sparse AB, A and B. There are other parallel clarifications, but instead of a list, I paraphrase a major earlier conclusion (in Epistemology; (Yarus 2012)) that includes most simpler re-statements.

Several proteins that inhibit apoptosis have been identified, including the members of the bcl-2 family, such as bcl-2

and bcl-xL, and the IAPs. The anti-apoptotic proteins bcl-2 and bcl-xL block the apoptotic event of mitochondrial cytochrome c release into the cytosol, and have been shown to mainly inhibit these two above-mentioned pathways. The gene encoding the IAP survivin has been cloned, and the protein characterized [18]. Survivin is thought to be expressed in the G2/M phase of the cell cycle in a cell cycle-regulated manner, and to be associated with microtubule formation of the mitotic spindle[19, 20]. As a member of the IAP family, survivin can block apoptosis triggered by a variety of apoptotic-stimulating factors. It can directly bind to and inhibit caspase-3 and caspase-7, which act at a common downstream part of the two major apoptotic pathways, and its Epigenetics Compound Library purchase overexpression in tumors has been implicated in resistance to a variety of apoptotic stimuli, including chemotherapy[17, 20]. For this reason, the survivin antisense

gene may facilitate both apoptotic pathways. Although survivin has long been considered a potential target for cancer therapy [18, 19, 21–25], the use of antisense cDNA and oligonucleotides to inhibit its expression has only recently been described [26, 27]. Previous studies have shown that reduction of survivin expression achieved by antisense strategies results in apoptotic cell death and sensitization to anticancer drugs in several tumor cell lines [26, 27]. These results suggest that survivin expression selleck inhibitor is likely important for cell survival or resistance to chemotherapy in carcinomas. CDDP acts in the G2/M phase of the cell cycle. Previous studies have shown that an increase in chemosensitivity is negatively correlated with survivin expression and positively correlated with rates of apoptosis[28]. The results of the study by Kojima et al

are consistent with expression of survivin in the G2/M phase[29]. These observations are consistent with an earlier finding [26] that interaction between survivin and microtubules of the mitotic spindle apparatus is necessary to prevent a default induction of apoptosis at L-NAME HCl the G2/M phase of the cell cycle. And it is reported that cisplatin induced caspase-9 activation and apoptosis in cisplatin-sensitive tumors[30]. Moreover, in a combination therapy experiment with CDDP, evidence was obtained that antisense-mediated downregulation of survivin can sensitize tumor cells to chemotherapy in vitro and in vivo [29]. Conclusions The survivin mutant had originally gained attention because it widely and specifically promoted apoptosis and enhanced chemotherapy, and its function and mechanism have been studied in various tumor types [9, 11, 12, 29]. However, there are many aspects of its mechanisms that are still unclear.

Increased clinician awareness of a specific clinical condition should be considered as an alternative source of an apparent rise in its incidence. However, this explanation is implausible in the case of PANF, as it remains a very rare complication, as evidenced in the current study with NF codes used in 0.004% of pregnancy-associated hospitalizations, and with most clinicians and hospitals in the state never encountering a PANF patient. It may thus be hypothesized that the present findings reflect actual rise in the incidence of PANF in the state. There are several possible explanations for rising incidence of PANF in this cohort. Chronic

see more comorbidities, well known to increase risk of infection and NF [24] were present in nearly one-third of PANF hospitalizations at the end of study period. In addition, obesity was increasingly present in our cohort. Obesity is a well-known risk factor for NF [6], has been associated with increased risk

of infections in pregnancy [25], and is more specifically linked with increasing risk of cesarean section [25, 26]. The latter has been often associated with PANF in prior reports [11, 12]. It is likely that the rate of obesity was underreported in this cohort, as can be the case in administrative data sets [27]. The rising rate of cesarean section in the US over the past decade [28] may have contributed to the rising incidence of PANF, a hypothesis supported by our findings of

the majority of reported NF events occurring as postpartum selleck hospitalizations. However, the de-identified structure of the administrative data set used in the present study precludes linking postpartum hospitalizations to specific preceding delivery hospitalizations to confirm this hypothesis. Additional study in other states and nationally is required to further elucidate the epidemiology of PANF. Findings of the race/ethnicity composition of the women in the present study and the predominance of Medicaid as the most common type Galactosylceramidase of health insurance, reflect the obstetric population in Texas, but may vary in other settings. The age distribution noted in the present cohort is in line with the majority of pregnancies occurring in the 20–34 years age group. The majority of PANF hospitalizations did not have reported chronic comorbidities. This finding contrasts reports on NF in the general population, with the majority of patients having one or more chronic illnesses [6]. However, when chronic comorbidities were present in patients, diabetes was the predominant one, similar to reports in the general population with NF [6, 7]. These results are in agreement with reported cases and case series of PANF, with most affected patients without chronic illness. Obesity was reported in about 1 in 5 of our patients in this study and, as noted earlier, may have been underreported.

Only 3 studies that employed matched protein intake met inclusion criteria for this analysis, however. Interestingly, 2 of the 3 showed no benefits OSI-906 molecular weight from timing. Moreover, another matched study actually found significantly greater increases in strength and lean body mass from a time-divided protein dose (i.e. morning and evening) compared with the same dose provided around the resistance training session [19]. However, this study had to be excluded from our analysis because it lacked adequate data to calculate an ES. The sum results of the matched-protein studies suggest that timing is superfluous provided adequate protein is ingested, although the small number of studies limits

the ability to draw firm conclusions on the matter. This meta-analysis had a number of strengths. For one, the quality of studies evaluated was high, with an average FK228 price PEDro score of 8.7. Also, the sample was relatively large (23 trials encompassing 478 subjects for strength outcomes and 525 subjects

for hypertrophy outcomes), affording good statistical power. In addition, strict inclusion/exclusion criteria were employed to reduce the potential for bias. Combined, these factors provide good confidence in the ability draw relevant inferences from findings. Another strength was the rigid adherence to proper coding practices. Coding was carried out by two of the investigators (BJS and AAA) and then cross-checked between coders. Coder drift was then assessed by random selection of studies to further ensure consistency of data. Finally and importantly, the study benefited from the use of meta-regression. This afforded the ability to examine the impact of moderator variables on effect size and explain heterogenecity between studies [64]. Although initial findings indicated an advantage conferred by protein timing, meta-regression revealed that results were confounded by discrepancies in consumption. This ultimately led to the determination that total protein intake rather than temporal factors explained any perceived benefits. There are several limitations to this analysis

see more that should be taken into consideration when drawing evidence-based conclusions. First, timing of the meals in the control groups varied significantly from study to study. Some provided protein as soon as 2 hours post workout while others delayed consumption for many hours. A recent review by Aragon and Schoenfeld [23] postulated that the anabolic window of opportunity may be as long as 4–6 hours around a training session, depending on the size and composition of the meal. Because the timing of intake in controls were all treated similarly in this meta-analysis, it is difficult to determine whether a clear anabolic window exists for protein consumption beyond which muscular adaptations suffer. Second, the majority of studies evaluated subjects who were inexperienced with resistance exercise.

RANK lacks intrinsic enzymatic activity in its intracellular domain, and it transduces signaling by recruiting adaptor molecules such as the TRAF family of proteins [8]. Genetic experiments

show that TRAF6 is required for osteoclast formation and osteoclast activation [30]. The binding of RANKL to its receptor RANK recruits TRAF6 and subsequently initiates a kinase cascade. RT-PCR analysis shows that kinsenoside did not reduce the RANKL-induced mRNA expression of RANK and TRAF-6, indicating that kinsenoside inhibits NF-κB activation through downstream kinase to TRAF6. The classical NF-κB Selleck Foretinib signaling pathway involves the activation of the IKK complex, which phosphorylates IκBα and targets them for ubiquitin-dependent degradation [8]. In the alternative IκB-independent pathway, direct phosphorylation of NF-κB subunit p65 by IKK also modulates NF-κB transcription activity [31]. In this study, kinsenoside inhibited RANKL-induced NF-κB activation see more in RAW 264.7 cells by inhibiting p-IκBα and p-p65. This indicates that kinsenoside inhibited NF-κB translocation through both IκBα-dependent and IκBα-independent pathways. IKK is the major upstream kinase of IκBα in the NF-κB signaling pathway. In this study, kinsenoside

did not inhibit IKK phosphorylation but suppressed the phosphorylation of IκBα and p65. Therefore, this study also investigates the effects of kinsenoside on IKK activity. Results show that kinsenoside significantly inhibits RANKL induction of IKK activity, suggesting that IKK is a critical target for kinsenoside in inhibiting RANKL-induced osteoclastogenesis. NFATc1 is likely a key regulator of RANKL-induced osteoclast differentiation, fusion, and activation [10].

NF-κB is important for the second initial induction of NFATc1. The binding of NF-κB to the NFATc1 promoter region induces NFATc1 gene expression, allowing NFATc1 to autoamplify its expression by binding to its own promoter. This, in turn, leads to the robust induction of NFATc1 during RANKL-induced osteoclast differentiation [32]. In this study, kinsenoside significantly suppressed RANKL-induced NF-κB translocation and NFATc1 nuclear transport. NFATc1 promotes the expression of osteoclast-specific genes such as TRAP, DC-STAMP, CAK, and MMP-9 [33–35]. In addition to histochemical marker for osteoclasts, TRAP also regulates bone resorption by mediating the degradation of endocytosed matrix products during transcytosis in activated osteoclasts [36]. DC-STAMP, a putative seven-transmembrane spanning protein, is essential for the cell–cell fusion of osteoclasts [37]. Proteinases are necessary for bone resorption. Delaisse et al. showed that CAK and MMP-9 are key proteinases in the bone resorption processes [38]. The RT-PCR analysis in this study shows that kinsenoside dose-dependently suppressed the mRNA expression of TRAP, DC-STAMP, CAK, and MMP-9.

Tremendous efforts have been made to improve the anticancer value of cisplatin [14–17]. Naturally occurring compounds from diets or medicinal plants are good candidates for increasing cisplatin’s anticancer

activity [18, 19]. The search for new compounds with high chemosensitization efficiency has never stopped. Although several studies have shown that saikosaponins exert anti-cancer activity in several cancer cell lines, the effect of combining saikosaponins with chemotherapeutic drugs has never been addressed. In the present study, we found that both SSa and SSd, Androgen Receptor Antagonist price two major triterpene saponins could sensitize a number types of human cancer cells to cisplatin-induced cell death. Importantly, we found that the chemosensitization effect of saikosaponin is mainly mediated by the induction of cellular reactive oxygen species (ROS) accumulation in cancer cells. To our knowledge, this is the first report showing that saikosaponin-induced cellular ROS accumulation mediates synergistic cytotoxicity in saikosaponins and cisplatin co-treated cancer cells. These results suggest that saikosaponins are good adjuvant agents for sensitizing cancer cells to cisplatin, highlighting that the combination of saikosaponins and cisplatin could be an effective therapeutic strategy for improving the anticancer value

Tubastatin A cost of cisplatin. Materials and methods Reagents Orotidine 5′-phosphate decarboxylase Saikosaponin-a and -d were purchased from Chinese National Institute of the Control Pharmaceutical and Biological Products (Beijing, China). Cisplatin, Butylated hydroxyanisole (BHA) and N-acetyl-L-cysteine (NAC) were from Sigma (St. Louis, MO, USA). The pan-caspase inhibitor zVAD-fmk was purchased from Calbiochem (La Jolla, CA, USA). Antibodies against active caspase-3, poly (ADP-ribose) polymerase (PARP) were purchased from BD bioscience (San Diego, CA, USA). Anti-β-actin was purchased from Protein Tech (Chicago, IL, USA). 5-(and -6)-chloromethyl-2′, 7′-dichlorodihydro-fluorescein diacetate acetyl ester (CM-H2DCFDA) and dihydroethidium (DHE) were purchased from Molecular Probes (Eugene, OR, USA). Cell

culture Two cervical cancer cell lines HeLa and Siha, an ovarian cancer cell line SKOV3, and a non-small cell lung cancer cell line A549 were from American Type Culture Collection (ATCC, Manassas, VA, USA) and grown in RPMI 1640 or DMEM supplemented with 10% fetal bovine serum (Hyclone, Thermo Scientific, Beijing, China), 1mmol/L glutamate, 100 units/mL penicillin, and 100 μg/mL streptomycin under standard incubator condition (37°C, 5% CO2). Cell death assay Cells were seeded in 96-well plate one day before treatment and then treated as indicated in each figure legend. Cell death was assessed based on release of lactate dehydrogenase (LDH) using a cytotoxicity detection kit (Promega, Madison, WI, USA) as described previously [20].